Merck Animal Health announces $1.3bn acquisition of Elanco’s aqua business
Merck Animal Health, a division of Merck & Co., Inc., headquartered in Rahway, New Jersey, USA, has announced its definitive agreement to acquire the aquaculture division of Elanco Animal Health Incorporated for $1.3 billion in cash. This strategic acquisition encompasses an innovative array of medicines, vaccines, nutritionals, and supplements tailored for aquatic species, alongside two […]